COMMUNIQUÉS West-GlobeNewswire

Cytori Reports Third Quarter 2017 Business and Financial Results

09/11/2017 - 22:25

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its third quarter 2017 financial results and provided updates on its corporate activity and [...]

Aileron Therapeutics Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:18

Company continues to advance clinical trials of lead product candidate ALRN-6924 in PTCL and AML/MDS Two abstracts selected for oral presentations at American Society of Hematology Annual Meeting, highlighting potential [...]

Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:15

Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn management CARLSBAD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ [...]

Caladrius Biosciences Reports 2017 Third Quarter Results

09/11/2017 - 22:11

BASKING RIDGE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update

09/11/2017 - 22:10

Announces Appointments of Michael Pehl as President and Chief Executive Officer and Brendan Delaney as Chief Commercial Officer Late-breaker Abstract on Updated Phase 2 Results of IMMU-132 in Patients with mTNBC [...]

Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook

09/11/2017 - 22:05

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal second quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]

Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth

09/11/2017 - 22:05

MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that its Board of Directors has voted to appoint Michael Pehl as President [...]

Aclaris Therapeutics Mourns the Passing of Board Member Richard A. Bierly

09/11/2017 - 22:05

MALVERN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update

09/11/2017 - 22:05

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Filed IND for KP484, A Super-Extended Release ADHD Methylphenidate Prodrug [...]

ChromaDex Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:05

- Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year - - Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN ™ - IRVINE, Calif., Nov. 09, 2017 (GLOBE [...]

Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results

09/11/2017 - 22:05

NDA for avatrombopag submitted to FDA Conference call scheduled for 4:30 p.m. EST today DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today reported its operating and [...]

ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update

09/11/2017 - 22:05

WESTMINSTER, Colo., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]

Codexis Reports Financial Results for the Third Quarter of 2017

09/11/2017 - 22:05

Product sales increase 71% over the prior year Affirms 2017 revenue guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a [...]

Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million

09/11/2017 - 22:05

Product revenue up 15%, compared to the June 2017 quarter Prescriptions filled were up 42% over last year and up 14% over the June 2017 quarter to 19,660 EBITDA loss reduced to $2.3 million Cash on hand equals $10 [...]

The Joint Corp. Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:05

- Grew Revenue to $6.5 Million, 19% Year-over-Year - Narrowed Net Loss by $2.2 Million - Achieved Positive Adjusted EBITDA for the First Time as a Public Company and for Corporate Clinics Segment SCOTTSDALE, Ariz., Nov [...]

Kura Oncology to Host Investor Day on November 16, 2017

09/11/2017 - 22:05

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq: KURA ) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

Fortress Biotech Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

09/11/2017 - 22:05

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

ICU Medical, Inc. Announces Third Quarter 2017 Results

09/11/2017 - 22:05

SAN CLEMENTE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress

09/11/2017 - 22:05

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced financial [...]